✦ LIBER ✦

The Skin and Circulating Immune Profile of Therapeutic IL-12/23 Blockade in Psoriasis Patients Treated with Ustekinumab

✍ Scribed by Carrie Brodmerkel; Katherine Li; Toyoko Kikuchi; Rosanne Fidelus-Gort; Artemis Khatcherian; Inna Novitskaya; Frederic Baribaud; James Krueger

Book ID: 113540769
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 44 KB
Volume: 131
Category: Article
ISSN: 1090-2341
DOI: 10.1016/j.clim.2009.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of ustekinumab, a hu

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

✍ Craig L Leonardi; Alexa B Kimball; Kim A Papp; Newman Yeilding; Cynthia Guzzo; Y 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 222 KB

Efficacy and safety of ustekinumab, a hu

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

✍ Kim A Papp; Richard G Langley; Mark Lebwohl; Gerald G Krueger; Philippe Szapary; 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 295 KB

Re-evaluation of the risk for major adve

Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials

✍ T. Tzellos; A. Kyrgidis; C. C. Zouboulis 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB

Ustekinumab, an anti-IL-12/23 p40 monocl

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials

✍ Kavanaugh, Arthur (author);Ritchlin, Christopher (author);Rahman, Proton (author 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 984 KB

Ustekinumab, an anti-IL-12/23 p40 monocl

✍ Kavanaugh, Arthur (author);Ritchlin, Christopher (author);Rahman, Proton (author 📂 Article 📅 2014 🏛 BMJ Publishing Group 🌐 English ⚖ 984 KB